Iatrogenic Creutzfeldt-Jakob disease subsequent to durai graft: Persisting risk after 1987

European Journal of Neurology

Volumn 10, Issue 5, 2003, Pages 521-523

  Boutoleau, C ^a   Guillon, B ^a   Martinez, F ^a   Vercelletto, M ^a   Faure, A ^b   Feve J R ^a  

^a CHU de Nantes   (France)

^b HÔTEL DIEU   (France)

Author keywords

Cadaveric dura mater graft; Creutzfeldt Jakob disease

Indexed keywords

ADULT; ARTICLE; BRAIN INJURY; CADAVER; CASE REPORT; CLINICAL FEATURE; CREUTZFELDT JAKOB DISEASE; DISEASE COURSE; DURA MATER; GRAFT INFECTION; HUMAN; IATROGENIC DISEASE; MALE; MYOCLONUS; PRIORITY JOURNAL; BRAIN TRANSPLANTATION; MIDDLE AGED; RISK FACTOR; TRANSPLANTATION;

ADULT; BRAIN TISSUE TRANSPLANTATION; CREUTZFELDT-JAKOB SYNDROME; DURA MATER; HUMANS; IATROGENIC DISEASE; MALE; MIDDLE AGED; RISK FACTORS;

EID: 0142087743     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-1331.2003.00632.x     Document Type: Article

References (13)

1. Brandel J-P, Delasnerie-Lauprêtre N, Laplanche JL, Hauw J-J, Alperovitch A (2000). Diagnosis of Creutzfeldt-Jakob disease. Effects of clinical criteria on incidence estimates. Neurology 54-1095-1099.
2. Brown P, Cervenakova L, Goldfarb LG et al. (1994). Iatrogenic Creutzfeldt-Jakob disease: an example of interplay between ancient genes and modern medicine. Neurology 44:291-293.
3. Brown P, Preece M, Brandel J-P et al. (2000). Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology 55:1075-1081.
4. Centers for Disease Control and Prevention (1987). Update: Creutzfeldt-Jakob disease in a patient receiving a cadaveric dura mater graft. MMWR Morb Mortal Wkly Rep 36:324-325.
5. Centers for Disease Control and Prevention (1997). Creutzfeldt-Jakob disease associated with cadaveric dura mater grafts - Japan, January 1979-May 1996. MMWR Morb Mortal Wkly Rep 46:1066-1069.
6. Clavel M, Clavel P (1996). Creutzfeldt-Jakob disease transmitted by dura mater graft. Eur Neurol 36:239-240.
7. Hannah EL, Belay ED, Gambetti P et al. (2001). Creutzfeldt-Jakob disease after receipt of a previously unimplicated brand of dura mater graft. Neurology 56:1080-1083.
8. Hoshi K, Yoshino H, Urata J, Nakamura Y, Yanagawa H, Sato T (2000). Creutzfeldt-Jakob disease associated with cadaveric dura mater grafts in Japan. Neurology 55:718-721.
9. Johnson RT, Gibbs CJ (1998). Creutzfeldt-Jakob disease and related transmissible spongiform encephalopathies. N Engl J Med 339:1994-2004.
10. Kimura K, Nonaka A, Tashiro H et al. (2001). Atypical form of dural graft associated Creutzfeldt-Jakob disease: report of postmortem case with review of the literature. J Neurol Neurosurg Psychiatry 70:696-699.
11. Nakamura Y, Aso E, Yanagawa H (1999). Relative risk of Creutzfeldt-Jakob disease with cadaveric dura transplantation in Japan. Neurology 53:218-220.
12. Tamai Y, Taguchi F, Miura S (1988). Inactivation of the Creutzfeldt-Jakob disease agent. Ann Neurol 24:466-467.
13. Tateishi J, Tashima T, Kitamoto T (1988). Inactivation of the Creutzfeldt-Jakob disease agent. Ann Neurol 24:466.